Answers are grounded in this paper and cite their sources.
Even if efficacy is eventually proven, screening must overcome multiple additional barriers to be highly cost-effective. Given the current uncertainty of benefits, the harms from invasive testing, and the high costs associated with screening, direct-to-consumer marketing of helical CT is not advisable.
No takes yet. Share an insight, caveat, or question.
Mahadevia et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: